Nucleus offers whole-genome sequencing that analyzes 100% of an individual's DNA, providing insights into genetic risks for over 800 health conditions, including cancers and heart disease. This technology enables users to understand their unique genetic predispositions and make informed lifestyle choices to enhance their health outcomes.
Funding
$17.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Existing genetic tests often analyze less than 0.1% of an individual's DNA, potentially missing critical health insights. This limited analysis can lead to an incomplete understanding of genetic predispositions for various diseases and traits.
Solution
Nucleus provides a whole-genome sequencing service that analyzes 100% of an individual's DNA to provide comprehensive insights into genetic risks for over 800 health conditions, including cancers, heart disease, and neurological disorders. By sequencing the entire genome, Nucleus aims to offer a more complete picture of an individual's genetic predispositions compared to traditional genetic tests. The service includes a home sample collection kit and updated reports as new genetic research emerges. Nucleus also offers Nucleus Embryo, a genetic optimization software designed to give children the best possible start in life.
Target Audience
The primary target audience includes individuals interested in understanding their genetic predispositions for various health conditions and traits, as well as couples seeking to optimize the genetic health of their embryos.
Features
- Whole-genome sequencing that analyzes 100% of an individual's DNA
- Screening for over 800 health conditions and traits, including cancer, heart disease, mental health, and longevity
- Updated reports and insights based on the latest genetic research
- Option to download raw DNA data
- Clinical-grade security with HIPAA compliance, CLIA certification, and CAP accreditation
- Sample processing and sequencing performed in the U.S.
- Nucleus Embryo software for genetic optimization of embryos